Thursday, September 23

Coronavirus: WHO advises against the use of remdesivir to treat hospitalized patients with covid-19

  • Drafting
  • BBC World News


Each remdesivir treatment costs governments more than $ 2,000.

The World Health Organization (WHO) has advised against the use of remdesivir as a treatment for hospitalized patients for covid-19.

In a guide prepared by international experts and published in the magazine The British Medical Journal, the health agency established that the drug “does not have no significant effect on mortality or other major complications for the patient“.

The WHO added that neither does it diminish “the need to require mechanical ventilation or the time to clinical improvement.”

Remdesivir is an antiviral which has been experimented with since the beginning of the pandemic as a possible treatment for acute cases of covid-19.

Leave a Reply

Your email address will not be published. Required fields are marked *